When Ubiquitin Meets NF-κB: A Trove for Anti-cancer Drug Development

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|18|3263-3275

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.18, 2013-06, pp. : 3263-3275

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inflammation and Cancer: When NF-&kgr;B Amalgamates the Perilous Partnership

By  

Current Cancer Drug Targets, Vol. 5, Iss. 5, 2005-08 ,pp. : 325-344

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting NF-κB for colorectal cancer

By Sakamoto Kei   Maeda Shin  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 6, 2010-06 ,pp. : 593-601

Informa Healthcare

Access to resources Recommend Favorite

NF-κB Inhibitors in Head and Neck Cancer

By  

Letters in Drug Design & Discovery, Vol. 14, Iss. 5, 2017-04 ,pp. : 619-633

Bentham Science Publishers

Access to resources Recommend Favorite

Systemic NF-κB activation in blood cells of breast cancer patients

By Adžić Miroslav   Nićiforović Ana   Vučić Vesna   Nešković-Konstantinović Zora   Spasić Snežana D.   Jones David R.   Radojčić Marija B.   Spasić Mihajlo B.  

Redox Report, Vol. 11, Iss. 1, 2006-02 ,pp. : 39-44

Maney Publishing

Access to resources Recommend Favorite

NF-&kgr;B Inhibitors for the Treatment of Inflammatory Diseases and Cancer

By  

Current Medicinal Chemistry, Vol. 14, Iss. 3, 2007-02 ,pp. : 367-376

Bentham Science Publishers

Access to resources Recommend Favorite